Title: Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Authors: Grothey, Axel * ×
Van Cutsem, Eric *
Sobrero, Alberto
Siena, Salvatore
Falcone, Alfredo
Ychou, Marc
Humblet, Yves
Bouché, Olivier
Mineur, Laurent
Barone, Carlo
Adenis, Antoine
Tabernero, Josep
Yoshino, Takayuki
Lenz, Heinz-Josef
Goldberg, Richard M
Sargent, Daniel J
Cihon, Frank
Cupit, Lisa
Wagner, Andrea
Laurent, Dirk
CORRECT Study Group #
Contributors: Prenen, Hans
Issue Date: Jan-2013
Publisher: The Lancet Publishing Group
Series Title: The Lancet vol:381 issue:9863 pages:303-12
Article number: 10.1016/S0140-6736(12)61900-X
Abstract: No treatment options are available for patients with metastatic colorectal cancer that progresses after all approved standard therapies, but many patients maintain a good performance status and could be candidates for further therapy. An international phase 3 trial was done to assess the multikinase inhibitor regorafenib in these patients.
ISSN: 0140-6736
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Clinical Digestive Oncology (+)
* (joint) first author
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science